Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/31280
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOoi, Esther MMen
dc.contributor.authorEllis, Katrina Len
dc.contributor.authorBarrett, P Hugh Ren
dc.contributor.authorWatts, Gerald Fen
dc.contributor.authorHung, Josephen
dc.contributor.authorBeilby, John Pen
dc.contributor.authorThompson, Peter Len
dc.contributor.authorStobie, Paulen
dc.contributor.authorMcQuillan, Brendan Men
dc.date.accessioned2021-08-11T05:46:59Z-
dc.date.available2021-08-11T05:46:59Z-
dc.date.issued2018-08-01-
dc.identifier.citationAtherosclerosis, v.275, p. 232-238en
dc.identifier.issn1879-1484en
dc.identifier.issn0021-9150en
dc.identifier.urihttps://hdl.handle.net/1959.11/31280-
dc.description.abstract<p><i>Background and aims:</i> Lipoprotein(a) [Lp(a)] is an emerging genetic risk factor for cardiovascular disease (CVD). We examined whether plasma Lp(a) concentration and apolipoprotein(a) [apo(a)] isoform size are associated with extent and severity of coronary artery disease (CAD), and the presence of carotid artery plaque.</p><p> <i>Methods:</i> We included in our study male participants (n = 263) from a cohort with angiographically defined premature CAD (Carotid Ultrasound in Patients with Ischemic Heart Disease). The angiographic extent and severity of CAD were determined by the modified Gensini and Coronary Artery Stenosis≥20% (CAGE) scores. Carotid artery plaque was assessed by bilateral carotid B-mode ultrasound. Apo(a) isoform size was determined by <i>LPA</i> Kringle IV-2 copy number (KIV-2 CN).</p><p> <i>Results:</i> Lp(a) concentration, but not KIV-2 CN, was positively associated with the Gensini score. The association remained significant following adjustment for conventional CVD risk factors (all <i>p</i> < 0.05). Lp(a) concentration and elevated Lp(a) [≥50 mg/dL] were positively associated with the CAGE≥20 score, independent of conventional CVD risk factors. KIV-2 C N Q1 (lowest KIV-2 CN quartile) was associated with CAGE≥20 score and KIV-2 CN, with the CAGE≥20 score in those without diabetes. In multivariate models that included phenotypic familial hypercholesterolemia or low-density lipoprotein cholesterol, Lp(a) concentration, but not KIV-2 CN, was independently associated with the Gensini and CAGE≥20 scores. No significant associations between Lp(a) concentration and KIV-2 CN with carotid artery plaque were observed.</p><p> <i>Conclusions:</i> Lp(a) concentration, but not apo(a) isoform size, is independently associated with angiographic extent and severity of CAD. Neither Lp(a) nor apo(a) isoform size is associated with carotid artery plaque.</p>en
dc.languageenen
dc.publisherElsevier Ireland Ltden
dc.relation.ispartofAtherosclerosisen
dc.titleLipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaqueen
dc.typeJournal Articleen
dc.identifier.doi10.1016/j.atherosclerosis.2018.06.863en
local.contributor.firstnameEsther MMen
local.contributor.firstnameKatrina Len
local.contributor.firstnameP Hugh Ren
local.contributor.firstnameGerald Fen
local.contributor.firstnameJosephen
local.contributor.firstnameJohn Pen
local.contributor.firstnamePeter Len
local.contributor.firstnamePaulen
local.contributor.firstnameBrendan Men
local.profile.schoolFaculty of Medicine and Healthen
local.profile.emailpbarret6@une.edu.auen
local.output.categoryC1en
local.record.placeauen
local.record.institutionUniversity of New Englanden
local.publisher.placeIrelanden
local.format.startpage232en
local.format.endpage238en
local.identifier.scopusid85049077169en
local.peerreviewedYesen
local.identifier.volume275en
local.title.subtitleAssociations with angiographic extent and severity of coronary artery disease, and carotid artery plaqueen
local.contributor.lastnameOoien
local.contributor.lastnameEllisen
local.contributor.lastnameBarretten
local.contributor.lastnameWattsen
local.contributor.lastnameHungen
local.contributor.lastnameBeilbyen
local.contributor.lastnameThompsonen
local.contributor.lastnameStobieen
local.contributor.lastnameMcQuillanen
dc.identifier.staffune-id:pbarret6en
local.profile.orcid0000-0003-3223-6125en
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.identifier.unepublicationidune:1959.11/31280en
local.date.onlineversion2018-06-16-
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
local.title.maintitleLipoprotein(a) and apolipoprotein(a) isoform sizeen
local.relation.fundingsourcenoteThis study was supported by grants-in-aid from the National Heart Foundation of Australia (ID:100422), Healthway, theWestern Australian Health Promotion Foundation and the Royal Perth Hospital Medical Research Foundation. E.M.M.O is a National Heart Foundation of Australia Future Leader Fellow (ID:100422).en
local.output.categorydescriptionC1 Refereed Article in a Scholarly Journalen
local.search.authorOoi, Esther MMen
local.search.authorEllis, Katrina Len
local.search.authorBarrett, P Hugh Ren
local.search.authorWatts, Gerald Fen
local.search.authorHung, Josephen
local.search.authorBeilby, John Pen
local.search.authorThompson, Peter Len
local.search.authorStobie, Paulen
local.search.authorMcQuillan, Brendan Men
local.uneassociationNoen
local.atsiresearchNoen
local.sensitive.culturalNoen
local.year.available2018en
local.year.published2018en
local.fileurl.closedpublishedhttps://rune.une.edu.au/web/retrieve/9d7860ab-a8db-4da0-bb92-bf7ccae85a0fen
local.subject.for2020320101 Cardiology (incl. cardiovascular diseases)en
local.subject.for2020320803 Systems physiologyen
local.subject.for2020320504 Medical biochemistry - lipidsen
local.subject.seo2020200105 Treatment of human diseases and conditionsen
dc.notification.tokene7e83883-881c-4bd8-91e0-4686cec603eeen
Appears in Collections:Journal Article
Files in This Item:
1 files
File SizeFormat 
Show simple item record

SCOPUSTM   
Citations

24
checked on Jul 20, 2024

Page view(s)

862
checked on Jul 23, 2023

Download(s)

2
checked on Jul 23, 2023
Google Media

Google ScholarTM

Check

Altmetric


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.